20
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Localization of Synaptophysin Immunoreactivity in the Human Liver

, , , , &
Pages 275-279 | Received 15 Apr 1993, Accepted 09 Aug 1993, Published online: 08 Jul 2009
 

Abstract

Kanda N, Fukuda Y, Imoto M, Koyama Y, Nakano I, Urano F. Localization of synaptophysin immunoreactivity in the human liver. Scand J Gastroenterol 1994;29:275-279.

The distribution of synaptophysin, specifically located in nerve terminals, was investigated immuno-histochemically in normal and diseased human livers in 4 patients with normal liver, 6 with chronic active hepatitis, 12 with cirrhosis, and 8 with hepatocellular carcinoma. In normal liver and chronic hepatitis synaptophysin immunoreactivity was detected in the lobules and portal areas. In cirrhosis it was found in the fibrous septum but in no pseudolobules. Parenchymal innervation would thus appear to cease with the development of cirrhosis, and denervation from the parenchyma may lead to various functional abnormalities in liver cirrhosis. In hepatocellular carcinoma no synaptophysin immunoreactivity was found along carcinomatous sinusoids. Immunoreactive spots were present in the capsules of hepatocellular carcinoma to a much lesser extent than in the fibrous septum of cirrhosis. Neural functions may thus have little effect on the microcirculation of hepatocellular carcinoma.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.